Aster DM Healthcare Limited

NSE ASTERDM.NS

Aster DM Healthcare Limited EBITDA for the year ending March 31, 2024: USD 73.32 M

Aster DM Healthcare Limited EBITDA is USD 73.32 M for the year ending March 31, 2024, a -43.21% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Aster DM Healthcare Limited EBITDA for the year ending March 31, 2023 was USD 129.10 M, a -38.11% change year over year.
Aster DM Healthcare Limited EBITDA for the year ending March 31, 2022 was USD 208.58 M, a 32.50% change year over year.
Aster DM Healthcare Limited EBITDA for the year ending March 31, 2021 was USD 157.42 M, a -9.23% change year over year.
Aster DM Healthcare Limited EBITDA for the year ending March 31, 2020 was USD 173.43 M, a 30.75% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NSE: ASTERDM.NS

Aster DM Healthcare Limited

CEO	Ms. Alisha Moopen
IPO Date	Feb. 26, 2018
Location	United Arab Emirates
Headquarters	Tower D - Aspect Tower
Employees	14,016
Sector	Health Care
Industries Hospitals & Clinics Drugstores & Retail Pharmacies Pharmaceuticals Specialty Retail

Description

Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company operates through Hospitals, Clinics, Retail Pharmacies, and Other segments. It provides primary, secondary, tertiary, and quaternary healthcare services through 29 hospitals, 120 clinics, 371 retail pharmacies, 114 labs, and patient experience centers under the Aster, Medcare, and Access brands. In addition, it offers healthcare retailing, diagnostic laboratories, digital health, and medical education services. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates.

Key trends

Past 5 years